Skip to content

Author

John R. Lukens

We have 2 of 148 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

AVIL is dispensable for baseline neurobehavioral and somatosensory function in mice.

Advillin (AVIL) is an actin-binding protein expressed in peripheral sensory neurons and Merkel cells, but aberrantly upregulated in several malignancies, including low-grade glioma, glioblastoma, and rhabdomyosarcoma. AVIL's oncogenic activity and restricted adult tissue expression make it an attractive therapeutic tar...

Sarah Lynch, Martyna Glowczyk-Gluc, Yi-Wei Wang et al. · 0 citations
Sep 2026

The nucleoside analog kamuvudine-9 shows protective and therapeutic efficacy in a mouse model of multiple sclerosis.

Innate immune signaling through inflammasome activation has been implicated in the pathogenesis of multiple sclerosis (MS). We previously demonstrated that nucleoside reverse transcriptase inhibitors (NRTIs), drugs approved to treat HIV and hepatitis B virus infections, and kamuvudines, safer NRTI derivatives, both inh...

P. Yerramothu, Kameshwari Ambati, Joseph Magagnoli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.